The primary objective of this study is to assess the safety and efficacy of the Celution Device in the processing of an autologous graft consisting of adipose derived regenerative cells (ADRCs) in the treatment of hand dysfunction due to scleroderma. ClinicalTrials.gov, 08/24/2015. (Also see Scleroderma Clinical Trials: ADRC Injections/STAR)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.